SciSparc Shares Are Trading Higher After the Company's MitoCareX Joint Venture Said It Identified Molecules That Could Be Used for Potential Anti-cancer Treatments
ScisPARC的股價走高,此前該公司的MitoCarex合資企業表示已確定可用於潛在抗癌治療的分子
SciSparc Shares Are Trading Higher After the Company's MitoCareX Joint Venture Said It Identified Molecules That Could Be Used for Potential Anti-cancer Treatments
ScisPARC的股價走高,此前該公司的MitoCarex合資企業表示已確定可用於潛在抗癌治療的分子
使用瀏覽器的分享功能,分享給你的好友吧